OBLN

Obalon Therapeutics (OBLN)

Obalon Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OBLN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/05/16	19:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/05/16	06:07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/04/27	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/04/24	22:07	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/04/14	06:25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/04/04	06:12	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/03/22	05:19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/03/18	06:02	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/15	03:25	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/11	06:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/08	23:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/03	23:02	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/03	20:05	Edgar (US Regulatory)	Withdrawal of a Registration Statement Withdrawal Request (rw Wd)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/02/02	20:01	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/01/27	20:02	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2023/01/13	07:10	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/12/21	07:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/12/21	06:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/11/15	07:27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/11/11	06:56	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/11/11	06:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/11/01	05:03	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/27	05:22	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/16	19:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/16	19:03	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/12	05:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/08/03	05:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/07/22	05:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/06/07	05:58	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc
2022/06/07	05:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OBLN	Obalon Therapeutics Inc